CB vs DMAC
Chubb Ltd (CB) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
DMAC does not have a complete income-statement cache yet.
CB currently screens at market cap $114.26B and trailing P/E 13.7. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the CB and DMAC stock pages for the full models.
Not investment advice.